🔎 Trials Near Me

Hjem › Kronisk fase myeloid leukæmi › Oregon

Kronisk fase myeloid leukæmi kliniske forsøg i Oregon

4 studier for Kronisk fase myeloid leukæmi søger deltagere på steder i Oregon.

Byer i Oregon

Officiel studietekst (engelsk)

Study of Olverembatinib (HQP1351) in Patients With CML-CP

  • Ascentage Investigative Site #1139, Portland
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06423911

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

  • Oregon Oncology Specialists Salem, Salem
RekruttererObservationsstudie
Alder 18 til 100 · Alle køn · Opdateret 20. jul. 2026 · NCT07091019

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

  • Oregon Health & Science University-Knight Cardiovascular Institute, Portland
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. apr. 2026 · NCT05304377

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

  • Willamette Valley Cancer Institute and Research Center, Eugene
  • Oregon Health & Science University, Portland
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 12. jan. 2026 · NCT06163430

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.